Zacks Investment Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,577
Closed -$243K 643
2023
Q2
$243K Buy
2,577
+64
+3% +$6.04K ﹤0.01% 568
2023
Q1
$208K Sell
2,513
-171
-6% -$14.1K ﹤0.01% 583
2022
Q4
$200K Sell
2,684
-494
-16% -$36.9K ﹤0.01% 568
2022
Q3
$263K Sell
3,178
-129,165
-98% -$10.7M ﹤0.01% 503
2022
Q2
$12.6M Buy
132,343
+6,354
+5% +$604K 0.19% 117
2022
Q1
$14.8M Buy
125,989
+464
+0.4% +$54.6K 0.21% 116
2021
Q4
$16.3M Buy
125,525
+4,598
+4% +$596K 0.23% 108
2021
Q3
$13.7M Buy
120,927
+2,024
+2% +$229K 0.22% 110
2021
Q2
$12.3M Buy
118,903
+7,097
+6% +$735K 0.2% 117
2021
Q1
$9.35M Sell
111,806
-2,077
-2% -$174K 0.17% 125
2020
Q4
$10.4M Sell
113,883
-34,733
-23% -$3.17M 0.19% 116
2020
Q3
$11.9M Sell
148,616
-39,020
-21% -$3.11M 0.24% 106
2020
Q2
$13M Buy
187,636
+6,160
+3% +$426K 0.29% 85
2020
Q1
$11.4M Buy
181,476
+31,839
+21% +$2M 0.28% 88
2019
Q4
$11.6M Sell
149,637
-1,401
-0.9% -$109K 0.22% 100
2019
Q3
$11.1M Buy
151,038
+2,742
+2% +$201K 0.22% 99
2019
Q2
$9.13M Buy
148,296
+2,982
+2% +$184K 0.19% 108
2019
Q1
$9.27M Sell
145,314
-4,236
-3% -$270K 0.2% 106
2018
Q4
$7.64M Buy
149,550
+5,865
+4% +$299K 0.18% 109
2018
Q3
$8.34M Sell
143,685
-53,241
-27% -$3.09M 0.17% 112
2018
Q2
$9.56M Buy
196,926
+921
+0.5% +$44.7K 0.21% 104
2018
Q1
$9.12M Buy
196,005
+5,508
+3% +$256K 0.2% 107
2017
Q4
$7.16M Sell
190,497
-9,744
-5% -$366K 0.16% 119
2017
Q3
$7.3M Buy
200,241
+87,714
+78% +$3.2M 0.17% 119
2017
Q2
$4.44M Buy
+112,527
New +$4.44M 0.11% 148
2015
Q2
Sell
-69,918
Closed -$1.66M 651
2015
Q1
$1.66M Sell
69,918
-41,196
-37% -$978K 0.05% 203
2014
Q4
$2.36M Buy
+111,114
New +$2.36M 0.08% 175